RxDoctor Payments Data

Whitney Hall, APRN

Family · Post Falls, IDNPI 1679012728

Payments from drug & device makers

$1,682in general payments, 2019–2025

Across 106 payments — averaging $15.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$225
  • GSK$223
  • AbbVie$180
  • Astellas Pharma US Inc$175
  • Amgen$165
  • Novo Nordisk$131
  • plus $584 from 18 others

What the payments were for

  • Food & beverage$1,682100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,682 in reported general payments places this provider in the 80th percentile of 809 family providers in Idaho.

See all family providers in Idaho

Medicare billing

Part B allowed, 2024
$32,975
Medicare patients
186
Services billed
530

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide38$45,530
JardianceEmpagliflozin34$43,983
EliquisApixaban48$38,913
MounjaroTirzepatide29$38,079
FarxigaDapagliflozin Propanediol25$23,933
JanuviaSitagliptin Phosphate12$9,289
VeozahFezolinetant12$6,323
Breo ElliptaFluticasone/Vilanterol13$5,044
Levothyroxine Sodium248$2,855
Atorvastatin Calcium169$2,300
BreynaBudesonide/Formoterol Fumarate20$2,032
Lurasidone Hcl12$2,019
Gabapentin80$1,982
Losartan Potassium162$1,935
Liothyronine Sodium36$1,738

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$131$45,53038 claims
Boehringer IngelheimJardiance$17$43,98334 claims
PfizerEliquis$81$38,91348 claims
Lilly USA, LLCMounjaro$53$38,07929 claims
AstraZenecaFarxiga$225$23,93325 claims
MerckJanuvia$35$9,28912 claims
Astellas Pharma US IncVeozah$175$6,32312 claims
GSKBreo Ellipta$223$5,04413 claims
AbbVieArmour Thyroid, Synthroid$180$3,09232 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 809 family providers in Idaho.

Other family in Post Falls

See the full list for Idaho

Where these figures come from

Is this you, or does something look wrong? →